R. Scalco

2.7k total citations · 2 hit papers
66 papers, 1.2k citations indexed

About

R. Scalco is a scholar working on Genetics, Molecular Biology and Rheumatology. According to data from OpenAlex, R. Scalco has authored 66 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Genetics, 26 papers in Molecular Biology and 18 papers in Rheumatology. Recurrent topics in R. Scalco's work include Neurogenetic and Muscular Disorders Research (27 papers), Glycogen Storage Diseases and Myoclonus (17 papers) and RNA modifications and cancer (14 papers). R. Scalco is often cited by papers focused on Neurogenetic and Muscular Disorders Research (27 papers), Glycogen Storage Diseases and Myoclonus (17 papers) and RNA modifications and cancer (14 papers). R. Scalco collaborates with scholars based in United Kingdom, United States and Switzerland. R. Scalco's co-authors include Rosaline C. M. Quinlivan, Ksenija Gorni, Laurent Servais, Basil T. Darras, Giovanni Baranello, Heinz Jungbluth, Riccardo Masson, Muna El-Khairi, Kristy Rose and Marianne Gerber and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Brain.

In The Last Decade

R. Scalco

60 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risdiplam in Type 1 Spinal Muscular Atrophy

2021 260 citations Giovanni Baranello, Basil T. Darras et al. profile →
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls

2021 160 citations Basil T. Darras, Riccardo Masson et al. profile →

Peers

Countries citing papers authored by R. Scalco

Since Specialization

Citations

This map shows the geographic impact of R. Scalco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Scalco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Scalco more than expected).

Fields of papers citing papers by R. Scalco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Scalco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Scalco. The network helps show where R. Scalco may publish in the future.

Co-authorship network of co-authors of R. Scalco

This figure shows the co-authorship network connecting the top 25 collaborators of R. Scalco. A scholar is included among the top collaborators of R. Scalco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Scalco. R. Scalco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	JEWELFISH: 24-month results from an open-label study in non-treatment-naïve patients with SMA receiving treatment with risdiplam 2024 ·Journal of Neurology ·Claudia A. Chiriboga, Claudio Bruno, Tina Duong, (unknown), Eugenio Mercuri, Janbernd Kirschner, Anna Kostera‐Pruszczyk, Birgit Jaber, Ksenija Gorni, Heidemarie Kletzl, (unknown), (unknown), R. Scalco, Paulo Fontoura, Francesco Muntoni, (unknown)	8
2	Crossover randomized controlled trial of bumetanide to rescue an attack of exercise induced hand weakness in hypokalaemic periodic paralysis 2024 ·Neuromuscular Disorders ·R. Scalco, Jasper M. Morrow, Andreea Manole, Iwona Skorupinska, Federico Ricciardi, Emma Matthews, Michael G. Hanna, Doreen Fialho	0
3	The influence of genotype on the natural history of types 1 - 3 spinal muscular atrophy 2024 ·Neuromuscular Disorders ·C. Simone Sutherland, S. Schneider, (unknown), Alex Simpson, (unknown), R. Scalco, (unknown), Ksenija Gorni, Darryl C. De Vivo, William B. Martens, Teresa M. Karrer	0
4	Sunfish parts 1 and 2: 4-year efficacy and safety data of risdiplam in types 2 and 3 spinal muscular atrophy (SMA) 2023 ·Journal of the Neurological Sciences ·Maryam Oskoui, Nicolas Deconinck, Elena Mazzone, A. Nascimento, John Day, Kayoko Saito, Carole Vuillerot, Giovanni Baranello, Odile Boespflug‐Tanguy, Nathalie Goemans, Janbernd Kirschner, Anna Kostera‐Pruszczyk, Laurent Servais, (unknown), Marianne Gerber, Ksenija Gorni, Carmen Martín, Wai Yin Yeung, R. Scalco, Eugenio Mercuri	2
5	Disease Burden of Spinal Muscular Atrophy: A Comparative Cohort Study Using Insurance Claims Data in the USA 2022 ·Journal of Neuromuscular Diseases ·(unknown), (unknown), Εleni Gaki, Scott Lipnick, Maryam Oskoui, R. Scalco, Basil T. Darras	4
6	Pooled Safety Data from the Risdiplam Clinical Trial Development Program (4184) 2021 ·Neurology ·Laurent Servais, Giovanni Baranello, Enrico Bertini, Claudia A. Chiriboga, Basil T. Darras, John Day, Nicolas Deconinck, Dirk Fischer, Nathalie Goemans, Janbernd Kirschner, Andrea Klein, Riccardo Masson, Maria Mazurkiewicz-Bełdzińska, (unknown), (unknown), Ksenija Gorni, Birgit Jaber, Tammy McIver, R. Scalco, Eugenio Mercuri	3
7	SUNFISH Part 2: 24-month Efficacy and Safety of Risdiplam in Patients with Type 2 or Non-ambulant Type 3 Spinal Muscular Atrophy (SMA) (2240) 2021 ·Neurology ·Maryam Oskoui, John Day, Nicolas Deconinck, Elena Mazzone, A. Nascimento, Kayoko Saito, Carole Vuillerot, Giovanni Baranello, (unknown), Nathalie Goemans, Janbernd Kirschner, Anna Kostera‐Pruszczyk, Laurent Servais, Marianne Gerber, Ksenija Gorni, Heidemarie Kletzl, (unknown), R. Scalco, Hannah Staunton, Wai Yin Yeung, Eugenio Mercuri	2
8	Pooled Safety Data from the Risdiplam (RG7916) Clinical Trial Development Program (1267) 2020 ·Neurology ·Giovanni Baranello, Enrico Bertini, Claudia A. Chiriboga, Basil T. Darras, John Day, Nicolas Deconinck, Dirk Fischer, Nathalie Goemans, Janbernd Kirschner, Andrea Klein, Riccardo Masson, Maria Mazurkiewicz-Bełdzińska, Laurent Servais, (unknown), Sabine Fuerst‐Recktenwald, Marianne Gerber, Ksenija Gorni, Birgit Jaber, Tammy McIver, R. Scalco, (unknown)	3
9	Results of an open label feasibility study of sodium valproate in people with McArdle disease 2020 ·Neuromuscular Disorders ·R. Scalco, (unknown), Nicoline Løkken, Christoffer Rasmus Vissing, Karen L. Madsen, Zuzanna Michalak, (unknown), Richard Godfrey, George Samandouras, Paul Bassett, Janice L. Holton, Thomas Krag, Ronald G. Haller, Caroline A. Sewry, (unknown), John Vissing, Rosaline C. M. Quinlivan	4
10	Improving specialised care for neuromuscular patients reduces the frequency of preventable emergency hospital admissions 2019 ·Neuromuscular Disorders ·R. Scalco, Rosaline C. M. Quinlivan, (unknown), Fatima Jaffer, Michael G. Hanna	2
11	Resistance Exercise Training in McArdle Disease: Myth or Reality? 2018 ·SHILAP Revista de lepidopterología ·(unknown), R. Scalco, Rosaline C. M. Quinlivan	8
12	Retinopathy Associated with Biallelic Mutations in PYGM (McArdle Disease) 2018 ·Ophthalmology ·Omar A. Mahroo, Kamron N. Khan, Genevieve Wright, (unknown), R. Scalco, Anthony G. Robson, Adnan Tufail, Michel Michaelides, Rosaline C. M. Quinlivan, Andrew R. Webster	12
13	Calpainopathy with macrophage-rich, regional inflammatory infiltrates 2017 ·Neuromuscular Disorders ·Peter W. Schütz, R. Scalco, Rita Barresi, Henry Houlden, M. Parton, Janice L. Holton	8
14	211th ENMC International Workshop: 2017 ·Neuromuscular Disorders ·Rosaline C. M. Quinlivan, Antoni L. Andreu, Ramón Martí, Richard Godfrey, Ronald G. Haller, Pascal Laforêt, Alejandro Lucía, (unknown), Miguel A. Martı́n, Andrea Martinuzzi, Anders Oldfors, Ximena Ortega, Serena Pagliarani, Päivi Piirilä, (unknown), Tomàs Pinós, R. Scalco, Benedikt Schoser, António Toscano, John Vissing, (unknown)	6
15	Transthyretin V122I amyloidosis with clinical and histological evidence of amyloid neuropathy and myopathy 2015 ·Neuromuscular Disorders ·(unknown), Ana L. Pelayo‐Negro, Zane Jaunmuktane, R. Scalco, David F. Hutt, (unknown), (unknown), Sebastian Brandner, Janice L. Holton, J. Blake, Carol Whelan, Ashutosh Wechalekar, Julian D. Gillmore, Philip N. Hawkins, Mary M. Reilly	19
16	Report on the EUROMAC McArdle Exercise Testing Workshop, Madrid, Spain, 11–12 July 2014 2015 ·Neuromuscular Disorders ·Rosaline C. M. Quinlivan, Alejandro Lucía, R. Scalco, Alfredo Santalla, (unknown), Richard Godfrey, Ramón Martí	5
17	Rhabdomyolysis: a genetic perspective 2015 ·Orphanet Journal of Rare Diseases ·R. Scalco, A. Gardiner, Robert D. S. Pitceathly, Edmar Zanoteli, Jéfferson Becker, Janice L. Holton, Henry Houlden, Heinz Jungbluth, Rosaline C. M. Quinlivan	103
18	Fatal cardiac involvement complicating antisynthetase syndrome 2014 ·BMJ Case Reports ·Stefen Brady, (unknown), R. Scalco, Henry Penn	7
19	Risk Factors among Stroke Subtypes in Brazil 2011 ·Journal of Stroke and Cerebrovascular Diseases ·Luiz Carlos Porcello Marrone, (unknown), (unknown), (unknown), R. Scalco, Andréa Garcia de Almeida, (unknown), A. Marrone, Jaderson Costa da Costa	32
20	Decreased anti-Müllerian hormone and altered ovarian follicular cohort in infertile patients with mild/minimal endometriosis 2007 ·Fertility and Sterility ·(unknown), Elisângela Arbo, R. Scalco, (unknown), Virgínia de Oliveira Rosa, João Sabino Cunha‐Filho	87

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact